Back | Next |
home / stock / pulm / pulm message board
Subject | By | Source | When |
---|---|---|---|
Yes, The Analyst's Target price is $30 a share! | Value_Investor | investorshub | 08/18/2022 3:48:06 PM |
Wow, Huge Cash Value --- $20.232 a share! | Value_Investor | investorshub | 08/18/2022 3:45:59 PM |
Wow, Huge Book Value --- $18.878 a share! | Value_Investor | investorshub | 08/18/2022 3:45:17 PM |
Wow, PULM did bounce to $7.5 last week! | Value_Investor | investorshub | 08/18/2022 3:43:18 PM |
whytestocks: $PULM News Article - Pulmatrix Announces Second Quarter 2022 Financial Results and Prov | whytestocks | investorshangout | 08/08/2022 6:56:02 PM |
100% Wrong Info.! The Analyst's Target price is | Value_Investor | investorshub | 05/16/2022 3:34:40 PM |
Wrong, read stocktwits thread for more info on pricetargets. | lakerol | investorshub | 04/04/2022 4:19:47 PM |
Yes, the Analyst's Target price is $30 and | Value_Investor | investorshub | 03/20/2022 6:46:39 PM |
UNREAL DUMPING | Disquisition | investorshub | 03/01/2022 4:50:21 PM |
COLASSAL DUMPING | Disquisition | investorshub | 02/28/2022 11:35:28 PM |
yep knew that was lurking | TheFinalCD | investorshub | 02/25/2022 12:07:48 AM |
Pulmatrix announces 1-for-20 reverse stock split, effective Mar.1 | Awl416 | investorshub | 02/24/2022 11:51:39 PM |
Stinks to hear - check back in 2 | riskon | investorshub | 02/16/2022 1:47:19 PM |
I lost about -$7500 on $PULM | TheFinalCD | investorshub | 02/14/2022 9:05:03 PM |
Vote for no RS will stick. Extend the | NlikeFlynn | investorshub | 02/10/2022 12:59:43 AM |
Big day tomorrow. What is everyone's prediction | BuyLow_Sell_High | investorshub | 02/09/2022 11:56:58 PM |
whytestocks: $PULM News Article - Pulmatrix Issues Letter to Stockholders | whytestocks | investorshangout | 02/01/2022 5:15:56 PM |
MM's keep walking it down to increase the | Ronin | investorshub | 01/31/2022 2:28:16 PM |
MMs buried this stock for a reason slowly | Ronin | investorshub | 01/26/2022 3:24:30 AM |
When is the reverse split? | TheFinalCD | investorshub | 01/22/2022 2:13:12 AM |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) PR Newswire Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) a...
Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire $16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results ...